 |
Observational Research
Molecular Discovery Studies
Molecular discovery studies are scientific studies involving
human biospecimens conducted in conjunction with the Genitourinary
Tissue Core. These studies seek to identify novel biomarkers to
enhance the diagnosis and treatment of genitourinary cancers by
collecting and banking blood, urine, and tissue for basic science,
epidemiologic, and clinical research studies.
Translational, genetics, genomics, proteomics, nutritional &
genetic epidemiology, expression arrays, novel imaging, and immunohistochemistry
studies are being conducted by utilizing tissue, serum, urine,
and plasma from consenting prostate, bladder, kidney and testis
cancer patients.
This research includes collaborations with other academic institutions
and industry, and is supported by the National Cancer Institute,
the Department of Defense, The American Association of Cancer
Research, The California Department of Health, and private industry.
Observational Research/Population Science
The observational research group seeks to understand modifiable
risk factors for diagnosis, prognosis, and survival to improve
quality of care and health-related quality of life for patients
with genitourinary cancer. Over 20 studies are being conducted
with topics that address behavioral science, diet, quality of
life, psychosocial issues, health disparities, and nutritional
and genetic epidemiology.
Funding to support observational research includes the National
Institutes of Health and National Cancer Institute, the Department
of Defense, the Prostate Cancer Foundation, the Veterans Affairs
Medical Center, and intramural sources. The observational research
group collaborations with Veterans Affairs,
Harvard School of Public Health & School of Medicine, and
Kaiser Permanente.
Urologic Oncology Database (UODB) Prostate
and Renal Studies
The Urologic Oncology Database records detailed clinical baseline
and follow-up data on patients seen and treated for genitourinary
cancer at UCSF to enhance clinical care and support research
in the department. The database contains data on more than
3,000 prostate cancer patients, and supports research studies
including biomarker discovery, nutritional epidemiology, novel
therapeutics, quality of life and high-risk markers. Extensive
clinical and pathological data on over 700 renal cancer patients
is also available. The database is funded intramurally and
by the UCSF prostate cancer SPORE grant funded by the National
Institutes of Health, National Cancer Institute.
Click here for details
about working with UODB data.
return
to top
|
|
|
|
Contents of This Page
Faculty
June Chan, ScD
Program Director
Matthew Cooperberg,
MD, MPH Co-director
Peter Carroll,
MD, MPH
Kirsten Greene,
MD
Sara Knight,
PhD
Maxwell Meng,
MD
Katsuto
Shinohara, MD
Key Staff
Jeanette Broering, RN, MS, MPH, Director of Data Procurement
and Quality Assurance
jbroering@urology.ucsf.edu
415/514-0203
UCSF CaPSURE Scholars Program
Janet Cowan
Programmer Analyst & CaPSURE Scholars Coordinator
jcowan@urology.ucsf.edu
Clinical Trials
Imelda Tenggara, Clinical Research Coordinator,
Supervisor
itenggara@urology.ucsf.edu
415/353-7348
Location
Helen
Diller Family Cancer Research Building
Helen Diller Family Cancer Research Building
1450 3rd Street
Academic Offices, Clinical Trials and G-CEPS
Mount Zion Medical Center
1600 Divisadero, 6th floor
Urology
Outcomes Research
3333 California Street, Suite 282
|
|
